Verapamil for cluster headache. Clinical pharmacology and possible mode of action.
about
Detection, isolation and characterization of principal synthetic route indicative impurities in verapamil hydrochlorideEvidence-based treatments for cluster headacheVerapamil, and its metabolite norverapamil, inhibit macrophage-induced, bacterial efflux pump-mediated tolerance to multiple anti-tubercular drugs.Cardiac safety in cluster headache patients using the very high dose of verapamil (≥720 mg/day).Verapamil results in increased blood levels of oncolytic adenovirus in treatment of patients with advanced cancerHeadache and cardiovascular disease: old symptoms, new proposals.Cluster headache--acute and prophylactic therapy.The possible use of the L-type calcium channel antagonist verapamil in drug-resistant epilepsy.The putative P-gp inhibitor telmisartan does not affect the transcellular permeability and cellular uptake of the calcium channel antagonist verapamil in the P-glycoprotein expressing cell line MDCK II MDR1.Acute, transitional and long-term cluster headache treatment: pharmacokinetic issues.Verapamil Blocks Scopolamine Enhancement Effect on Memory Consolidation in Passive Avoidance Task in Rats.Dorsolateral medullary ischemic infarction causing autonomic dysfunction and headache: a case report.β-catenin promoter ChIP-chip reveals potential schizophrenia and bipolar disorder gene network.Management of Cluster Headache
P2860
Q24610557-1BB01C94-8E7A-437B-B97E-0D6097CF2FD4Q26774849-C27BC011-E796-4D0A-949B-A5C3BC594E53Q33947806-38BF21F5-FAD0-42BC-8819-64BC7E1EC4ACQ34770935-90968EAC-59AE-4C29-A566-3F7BF252C875Q35665175-B4E86982-4BF3-483B-9750-77B34EF9D538Q37798812-3A66677A-C890-4AD4-83FD-FF6B7658029EQ37834036-B05DA848-5CDA-4AC2-BEEF-676367D8A89DQ38633232-5A9B1220-CDF6-44A7-BA04-15D86D0BDDBEQ38853359-6FB29504-D97B-4AF4-8338-33ACC18056B6Q38866983-A58BB383-7D36-48CF-9433-23A3982DF72AQ41527014-2C60B3B0-B0F4-47D9-B148-4D7F9AD1D8CFQ42175303-024E4BFC-3A12-47FA-BFB2-BD00E87D29E9Q42976183-8CFB2341-6D81-4309-AF13-3FEFEF4C3EC6Q55918731-F441FD76-42DD-47E2-BA2D-047F7FD8C16F
P2860
Verapamil for cluster headache. Clinical pharmacology and possible mode of action.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Verapamil for cluster headache. Clinical pharmacology and possible mode of action.
@en
Verapamil for cluster headache. Clinical pharmacology and possible mode of action.
@nl
type
label
Verapamil for cluster headache. Clinical pharmacology and possible mode of action.
@en
Verapamil for cluster headache. Clinical pharmacology and possible mode of action.
@nl
prefLabel
Verapamil for cluster headache. Clinical pharmacology and possible mode of action.
@en
Verapamil for cluster headache. Clinical pharmacology and possible mode of action.
@nl
P2860
P1433
P1476
Verapamil for cluster headache. Clinical pharmacology and possible mode of action.
@en
P2860
P304
P356
10.1111/J.1526-4610.2008.01298.X
P577
2009-01-01T00:00:00Z